Citadel Advisors’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
3,607,967
+884,604
| +32% | +$3.56M | ﹤0.01% | 1152 |
|
|
2025
Q1 | $9.45M | Hold |
2,723,363
| – | – | ﹤0.01% | 1286 |
|
|
2024
Q4 | $17.9M | Hold |
2,723,363
| – | – | ﹤0.01% | 986 |
|
|
2024
Q3 | $24.6M | Buy |
2,723,363
+164,752
| +6% | +$1.49M | ﹤0.01% | 761 |
|
|
2024
Q2 | $41M | Buy |
2,558,611
+55,630
| +2% | +$892K | 0.01% | 558 |
|
|
2024
Q1 | $38.9M | Buy |
2,502,981
+418,736
| +20% | +$6.51M | 0.01% | 582 |
|
|
2023
Q4 | $28M | Buy |
+2,084,245
| New | +$28M | 0.01% | 712 |
|